πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12295940

Viral inhibitors, the synthesis thereof, and intermediates thereto

Takeda Pharmaceutical Company Limited Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295941

Viral inhibitors, the synthesis thereof, and intermediates thereto

Takeda Pharmaceutical Company Limited Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295929

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297203

Pyrrolopyrimidine ITK inhibitors

Aclaris Therapeutics, Inc. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295971

Compositions and methods for enhancing adoptive T cell therapeutics

The Regents of the University of California Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296048

Polymer particles for neutrophil injury

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296004

Recombinant virus with diminished latency and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296050

Pharmaceutical compositions comprising maralixibat and uses thereof

MIRUM PHARMACEUTICALS, INC. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297279

Compositions and methods for treating pain in subjects with rheumatoid arthritis

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295909

Adapter for use in a planetary mixer

MEDISCA PHARMACEUTIQUE INC. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295394

Water-soluble additive composition

SUMITOMO BAKELITE CO., LTD. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295362

Formulations and processes for CAR T cell drug products

Allogene Therapeutics, Inc. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12295974

Compositions and methods for transplantation of colon microbiota

Regents of the University of Minnesota Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296023

Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle pro

The Regents of the University of California Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296013

Photosensitizing antibody-fluorophore conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297186

Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

AGOMAB SPAIN, S.L.U. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297202

RIP1K inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297207

Maytansinoid derivatives, conjugates thereof, and methods of use

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12292445

Methods of selecting subjects for treatment with metabolomic modulators

The Regents of the University of California Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12291058

Dispersions for additive manufacturing comprising discrete carbon nanotubes

MOLECULAR REBAR DESIGN, LLC Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12291709

Compositions and methods for modulating apolipoprotein (a) expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12292441

Recombinant Acinetobacter baumannii strain AB5075

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12291565

Tau binding compounds

VOYAGER THERAPEUTICS, INC. Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12290596

Compositions and methods for the treatment of opioid overdose

Indivior UK Limited Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted